PACB News and Press, Pacific Biosciences of California Inc. From 02/27/23

PacBio to Present at Cowen's 43rd Annual Health Care Conference PR Newswire MENLO PARK, Calif. , Feb. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be partic...

Summary PacBio's fourth quarter numbers were ugly, but that was expected as the company prepares for the launch of its next generation of long-read sequencers and its entry into short-read sequencing. The Revio long-read sequencer offers another significant step up in throughput and cos...

Pacific Biosciences of California, Inc. (PACB) Q4 2022 Earnings Conference Call February 16, 2023 04:30 PM ET Company Participants Todd Friedman - Director, Investor Relations Christian Henry - President & Chief Executive Officer Susan Kim - Chief Financial Officer...

Pacific Biosciences of California press release ( NASDAQ: PACB ): Q4 Non-GAAP EPS of -$0.35 beats by $0.02 . Revenue of $27.35M (-24.0% Y/Y) beats by $0.06M . Received record orders in the fourth quarter, including orders for 96 instruments, which included orders for 7...

PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results PR Newswire MENLO PARK, Calif. , Feb. 16, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2022 . ...

Pacific Biosciences of California ( NASDAQ: PACB ) is scheduled to announce Q4 earnings results on Thursday, February 16th, after market close. The consensus EPS Estimate is -$0.37 (-23.3% Y/Y) and the consensus Revenue Estimate is $27.29M (-24.2% Y/Y). Over the last 1 year, P...

Summary Singular Genomics Systems is a unique opportunity to invest in a commercially-viable startup at the forefront of a rapidly expanding field. The company has adequate funding to maintain its current level of commercialization and sales activity for a few years. Capital gains c...

After a blistering start to the year, small-cap biotech stocks made a U-turn in the second week of February. Speaking to this point, shares of the optical genome mapping company Bionano Genomics (NASDAQ: BNGO) , the next-generation DNA sequencing company Pacific Biosciences of Californi...

PacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions PR Newswire End-to-End Solutions Planned to Support Key Customer Applications With Increased Cost Flexibility on Long-Read Sequencing Systems MENLO PARK, Calif. , Feb. 7, 2023 /PRN...

Summary The gene sequencing market is ripe for disruption. ILMN suffers from multiple strategic setbacks that will likely impact margins for years. Oxford Nanopore and Pacific Biosciences will likely grow at a faster pace than ILMN. The industry trades at high price multiples. ...